<?xml version="1.0" encoding="UTF-8"?>
<doc:document xmlns:doc="http://www.elsevier.com/xml/document/schema"
              xmlns:dp="http://www.elsevier.com/xml/common/doc-properties/schema"
              xmlns:cps="http://www.elsevier.com/xml/common/consyn-properties/schema"
              xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#"
              xmlns:dct="http://purl.org/dc/terms/"
              xmlns:prism="http://prismstandard.org/namespaces/basic/2.0/"
              xmlns:oa="http://vtw.elsevier.com/data/ns/properties/OpenAccess-1/"
              xmlns:bam="http://vtw.elsevier.com/data/voc/ns/bam-vtw-1/"
              xmlns:cp="http://vtw.elsevier.com/data/ns/properties/Copyright-1/"
              xmlns:cja="http://www.elsevier.com/xml/cja/schema"
              xmlns:ja="http://www.elsevier.com/xml/ja/schema"
              xmlns:bk="http://www.elsevier.com/xml/bk/schema"
              xmlns:ce="http://www.elsevier.com/xml/common/schema"
              xmlns:mml="http://www.w3.org/1998/Math/MathML"
              xmlns:cals="http://www.elsevier.com/xml/common/cals/schema"
              xmlns:tb="http://www.elsevier.com/xml/common/table/schema"
              xmlns:sa="http://www.elsevier.com/xml/common/struct-aff/schema"
              xmlns:sb="http://www.elsevier.com/xml/common/struct-bib/schema"
              xmlns:xlink="http://www.w3.org/1999/xlink">
   <rdf:RDF>
      <rdf:Description rdf:about="http://dx.doi.org/10.1016/j.phyplu.2022.100227">
         <dct:format>application/xml</dct:format>
         <dct:title>Screening of Phytochemicals as Potential Inhibitors of Breast Cancer using Structure Based Multitargeted Molecular Docking Analysis</dct:title>
         <dct:creator>Vikas Jha</dct:creator>
         <dct:creator>Sakshi Devkar</dct:creator>
         <dct:creator>Kunal Gharat</dct:creator>
         <dct:creator>Sankalp Kasbe</dct:creator>
         <dct:creator>Darpan Kaur Matharoo</dct:creator>
         <dct:creator>Shalmali Pendse</dct:creator>
         <dct:creator>Anjali Bhosale</dct:creator>
         <dct:creator>Agraj Bhargava</dct:creator>
         <dct:subject>
            <rdf:Bag>
               <rdf:li>Breast Cancer</rdf:li>
               <rdf:li>Bioavailability</rdf:li>
               <rdf:li>In Silico</rdf:li>
               <rdf:li>Multiple Targets</rdf:li>
               <rdf:li>Molecular Docking</rdf:li>
               <rdf:li>Phytochemicals</rdf:li>
               <rdf:li>Toxicity</rdf:li>
            </rdf:Bag>
         </dct:subject>
         <dct:description>Phytomedicine Plus 2 (2022). doi:10.1016/j.phyplu.2022.100227</dct:description>
         <prism:aggregationType>journal</prism:aggregationType>
         <prism:publicationName>Phytomedicine Plus</prism:publicationName>
         <prism:copyright>© 2022 The Author(s). Published by Elsevier B.V.</prism:copyright>
         <dct:publisher>Elsevier B.V.</dct:publisher>
         <prism:issn>2667-0313</prism:issn>
         <prism:volume>2</prism:volume>
         <prism:number>2</prism:number>
         <prism:coverDisplayDate>May 2022</prism:coverDisplayDate>
         <prism:doi>10.1016/j.phyplu.2022.100227</prism:doi>
         <prism:url>http://dx.doi.org/10.1016/j.phyplu.2022.100227</prism:url>
         <dct:identifier>doi:10.1016/j.phyplu.2022.100227</dct:identifier>
         <bam:articleNumber>100227</bam:articleNumber>
         <oa:openAccessInformation>
            <oa:openAccessStatus xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://vtw.elsevier.com/data/voc/oa/OpenAccessStatus#Full</oa:openAccessStatus>
            <oa:openAccessEffective xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">2022-01-26T07:03:33Z</oa:openAccessEffective>
            <oa:sponsor xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
               <oa:sponsorType>http://vtw.elsevier.com/data/voc/oa/SponsorType#Author</oa:sponsorType>
            </oa:sponsor>
            <oa:userLicense xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">http://creativecommons.org/licenses/by-nc-nd/4.0/</oa:userLicense>
         </oa:openAccessInformation>
         <cp:licenseLine xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">This is an open access article under the CC BY-NC-ND license.</cp:licenseLine>
      </rdf:Description>
   </rdf:RDF>
   <dp:document-properties>
      <dp:aggregation-type>Journals</dp:aggregation-type>
      <dp:version-number>S250.1</dp:version-number>
   </dp:document-properties>
   <ja:article docsubtype="fla" version="5.6" xml:lang="en">
      <ja:item-info>
         <ja:jid>PHYPLU</ja:jid>
         <ja:aid>100227</ja:aid>
         <ce:article-number>100227</ce:article-number>
         <ce:pii>S2667-0313(22)00013-6</ce:pii>
         <ce:doi>10.1016/j.phyplu.2022.100227</ce:doi>
         <ce:copyright type="other" year="2022">The Author(s)</ce:copyright>
      </ja:item-info>
      <ja:head>
         <ce:title id="tte0002">Screening of Phytochemicals as Potential Inhibitors of Breast Cancer using Structure Based Multitargeted Molecular Docking Analysis</ce:title>
         <ce:author-group id="aut0001">
            <ce:author id="au0001"
                       author-id="S2667031322000136-89c98f8d5bce6343c28b89823c98c994">
               <ce:given-name>Vikas</ce:given-name>
               <ce:surname>Jha</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
               <ce:cross-ref refid="cor0001">
                  <ce:sup loc="post">⁎</ce:sup>
               </ce:cross-ref>
               <ce:e-address id="ead0001" type="email" xlink:href="mailto:vikasjjha7@gmail.com">vikasjjha7@gmail.com</ce:e-address>
            </ce:author>
            <ce:author id="au0002"
                       author-id="S2667031322000136-cab5697f21d0bcc7efdb7e7ae6db97ba">
               <ce:given-name>Sakshi</ce:given-name>
               <ce:surname>Devkar</ce:surname>
               <ce:cross-ref refid="aff0002">
                  <ce:sup loc="post">b</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0003"
                       author-id="S2667031322000136-e5831cb0adb1dd8eac7e517ef9995f65">
               <ce:given-name>Kunal</ce:given-name>
               <ce:surname>Gharat</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0004"
                       author-id="S2667031322000136-993989534e8c36a9be0cc8e15522ac83">
               <ce:given-name>Sankalp</ce:given-name>
               <ce:surname>Kasbe</ce:surname>
               <ce:cross-ref refid="aff0003">
                  <ce:sup loc="post">c</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0005"
                       author-id="S2667031322000136-dfb00fbc49ca46e76c158c340dd6072e">
               <ce:given-name>Darpan Kaur</ce:given-name>
               <ce:surname>Matharoo</ce:surname>
               <ce:cross-ref refid="aff0003">
                  <ce:sup loc="post">c</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0006"
                       author-id="S2667031322000136-19b9de676ce8ae1aebdf0f9defbcf24d">
               <ce:given-name>Shalmali</ce:given-name>
               <ce:surname>Pendse</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0007"
                       author-id="S2667031322000136-40cc5d1d7a1a2a0a82ba080207e24064">
               <ce:given-name>Anjali</ce:given-name>
               <ce:surname>Bhosale</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:author id="au0008"
                       author-id="S2667031322000136-90e8e7835e0530685357551d265b63ec">
               <ce:given-name>Agraj</ce:given-name>
               <ce:surname>Bhargava</ce:surname>
               <ce:cross-ref refid="aff0001">
                  <ce:sup loc="post">a</ce:sup>
               </ce:cross-ref>
            </ce:author>
            <ce:affiliation id="aff0001"
                            affiliation-id="S2667031322000136-480362c1ef15c0773c9f97182327837b">
               <ce:label>a</ce:label>
               <ce:textfn id="cetextfn0001">National Facility for Biopharmaceuticals, G. N. Khalsa College, Matunga, Mumbai, Maharashtra, India</ce:textfn>
               <sa:affiliation>
                  <sa:organization>National Facility for Biopharmaceuticals, G. N. Khalsa College, Matunga</sa:organization>
                  <sa:city>Mumbai</sa:city>
                  <sa:state>Maharashtra</sa:state>
                  <sa:country>India</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0001">aNational Facility for Biopharmaceuticals, G. N. Khalsa College, Matunga, Mumbai, Maharashtra, India</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0002"
                            affiliation-id="S2667031322000136-5e8fe59141dafad3068d4d7f299cc35e">
               <ce:label>b</ce:label>
               <ce:textfn id="cetextfn0002">Department of Biotechnology, Kishinchand Chellaram College Vidyasagar, Mumbai, Maharashtra 400020, India</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Department of Biotechnology</sa:organization>
                  <sa:organization>Kishinchand Chellaram College Vidyasagar</sa:organization>
                  <sa:city>Mumbai</sa:city>
                  <sa:state>Maharashtra</sa:state>
                  <sa:postal-code>400020</sa:postal-code>
                  <sa:country>India</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0002">bDepartment of Biotechnology, Kishinchand Chellaram College Vidyasagar, Mumbai, Maharashtra 400020, India</ce:source-text>
            </ce:affiliation>
            <ce:affiliation id="aff0003"
                            affiliation-id="S2667031322000136-5d64cebb7711cc1e25148b51fb2defdd">
               <ce:label>c</ce:label>
               <ce:textfn id="cetextfn0003">Department of Five Years Integrated Course in Bioanalytical Sciences, GNIRD, Guru Nanak Khalsa College, Matunga, Mumbai 19, India</ce:textfn>
               <sa:affiliation>
                  <sa:organization>Department of Five Years Integrated Course in Bioanalytical Sciences</sa:organization>
                  <sa:organization>GNIRD, Guru Nanak Khalsa College</sa:organization>
                  <sa:address-line>Matunga</sa:address-line>
                  <sa:city>Mumbai 19</sa:city>
                  <sa:country>India</sa:country>
               </sa:affiliation>
               <ce:source-text id="staff0003">cDepartment of Five Years Integrated Course in Bioanalytical Sciences, GNIRD, Guru Nanak Khalsa College, Matunga, Mumbai 19, India</ce:source-text>
            </ce:affiliation>
            <ce:correspondence id="cor0001">
               <ce:label>⁎</ce:label>
               <ce:text id="cetext0001">Corresponding author,</ce:text>
            </ce:correspondence>
         </ce:author-group>
         <ce:date-received day="12" month="10" year="2021"/>
         <ce:date-revised day="4" month="1" year="2022"/>
         <ce:date-accepted day="25" month="1" year="2022"/>
         <ce:abstract id="abs0001" view="all" class="author">
            <ce:section-title id="cesectitle0001">Abstract</ce:section-title>
            <ce:abstract-sec id="abss0001" role="background" view="all">
               <ce:section-title id="cesectitle0002">Background</ce:section-title>
               <ce:simple-para id="spara016" view="all">
                  <ce:bold>:</ce:bold> Breast cancer being one of the most common cancers in women all around the world is a dominant cause of deaths occurring all around the globe. The available potent drugs for breast cancer show adverse effects and are found ineffective in patients. Furthermore, this acquired resistance that is vulnerable to cancer-related mutations and the resistance due to minor heterogeneous subpopulation may improve the treatment's inefficiency. This study aims to find suitable and effective bioactive compounds by screening numerous phytochemical molecules using a bioinformatic approach to develop an effective treatment for breast cancer.</ce:simple-para>
            </ce:abstract-sec>
            <ce:abstract-sec id="abss0002" role="materials-methods" view="all">
               <ce:section-title id="cesectitle0003">Methods</ce:section-title>
               <ce:simple-para id="spara017" view="all">
                  <ce:bold>:</ce:bold> In this study, the proteins that play a crucial role in breast cancer were used. The phytochemicals with known anticancer properties were scrutinized based on pathophysiological relevance, pharmacokinetic characteristics, and drug-like properties using the SwissADME web server. These phytochemicals were filtered through the process of docking, and the top five ligands for each protein were selected. Further, these shortlisted molecules' bioavailability and toxicity profiles were assessed using SwissADME and ADMETlab 2.0 web server, respectively.</ce:simple-para>
            </ce:abstract-sec>
            <ce:abstract-sec id="abss0003" role="results" view="all">
               <ce:section-title id="cesectitle0004">Results</ce:section-title>
               <ce:simple-para id="spara018" view="all">
                  <ce:bold>:</ce:bold> The six target receptors such as CTLA4, CDK8, EGFR, mTOR, p53R2 and PR were identified using a bibliographic study. Further, the screening of 68 phytochemicals resulted in 38 molecules that satisfied the Lipinski rule. Owing to the binding affinity scores of 38 molecules, the top 5 molecules with each receptor were chosen, resulting in the top 10 drug candidates. Out of these ten, only five molecules, such as Ursolic acid, Enterolactone, Parthenolide, Berberine, and its derivative Berberastine, were safe and non-toxic.</ce:simple-para>
            </ce:abstract-sec>
            <ce:abstract-sec id="abss0004" role="conclusion" view="all">
               <ce:section-title id="cesectitle0005">Conclusion</ce:section-title>
               <ce:simple-para id="spara019" view="all">
                  <ce:bold>:</ce:bold> The screening of numerous phytochemicals against pivotal breast cancer target proteins led to the five most promising therapeutic candidates. We believe these findings will aid in the development of traditional medicine-based therapy methods and the identification of viable hits for future lead optimization in breast cancer medication development.</ce:simple-para>
            </ce:abstract-sec>
         </ce:abstract>
         <ce:keywords id="keys0001" view="all" class="keyword">
            <ce:section-title id="cesectitle0006">Keywords</ce:section-title>
            <ce:keyword id="key0001">
               <ce:text id="cetext0002">Breast Cancer</ce:text>
            </ce:keyword>
            <ce:keyword id="key0002">
               <ce:text id="cetext0003">Bioavailability</ce:text>
            </ce:keyword>
            <ce:keyword id="key0003">
               <ce:text id="cetext0004">
                  <ce:italic>In Silico</ce:italic>
               </ce:text>
            </ce:keyword>
            <ce:keyword id="key0004">
               <ce:text id="cetext0005">Multiple Targets</ce:text>
            </ce:keyword>
            <ce:keyword id="key0005">
               <ce:text id="cetext0006">Molecular Docking</ce:text>
            </ce:keyword>
            <ce:keyword id="key0006">
               <ce:text id="cetext0007">Phytochemicals</ce:text>
            </ce:keyword>
            <ce:keyword id="key0007">
               <ce:text id="cetext0008">Toxicity</ce:text>
            </ce:keyword>
         </ce:keywords>
         <ce:keywords class="abr" id="pc_x4URDASmsqXUB6T3NQdXhO0cM9eiQq9y" view="all">
            <ce:keyword id="pc_yogBaPLJkp">
               <ce:text>CTLA4:</ce:text>
               <ce:keyword id="pc_v0Hi7fiMDy">
                  <ce:text>Cytotoxic T lymphocyte antigen 4</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_TADDlT91Ql">
               <ce:text>CDK8:</ce:text>
               <ce:keyword id="pc_lhYAVfJsme">
                  <ce:text>Cyclin-dependent kinase 8</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_On0nr4ePUm">
               <ce:text>CASTp:</ce:text>
               <ce:keyword id="pc_jln6tplt7U">
                  <ce:text>Computed Atlas of Surface Topography of proteins</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_9XxYPrLQ10">
               <ce:text>DMAPT:</ce:text>
               <ce:keyword id="pc_huTJxZ7hBA">
                  <ce:text>Dimethylamino parthenolide</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_ZkvRq6P9Gg">
               <ce:text>EGFR:</ce:text>
               <ce:keyword id="pc_NMwLbt5k1L">
                  <ce:text>Epidermal growth factor receptor</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_ukINPhBEJ8">
               <ce:text>IBC:</ce:text>
               <ce:keyword id="pc_zw6hgcrsLj">
                  <ce:text>Inflammatory breast cancer</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_VLJhPJ266t">
               <ce:text>MCF-7:</ce:text>
               <ce:keyword id="pc_iOlalapvIA">
                  <ce:text>Caucasian metastatic breast cancer</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_WIE9VmN1yS">
               <ce:text>mTOR:</ce:text>
               <ce:keyword id="pc_CyYotVCvgh">
                  <ce:text>Mammalian target of rapamycin</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_Nt0DpXtcTh">
               <ce:text>p53R2:</ce:text>
               <ce:keyword id="pc_jHbOeBSPS1">
                  <ce:text>p53-inducible homologue of the R2 subunit of ribonucleotide reductase</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_2CMj02Imsv">
               <ce:text>PR:</ce:text>
               <ce:keyword id="pc_cuB51aE1ZX">
                  <ce:text>Progesterone receptor</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_cqQPBodO9f">
               <ce:text>TNBC:</ce:text>
               <ce:keyword id="pc_PNgUkDGcwl">
                  <ce:text>Triple-negative breast cancer</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_RWWcaKAUSa">
               <ce:text>TAMs:</ce:text>
               <ce:keyword id="pc_TjrR6yv4L8">
                  <ce:text>Tumor-associated macrophages</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_TnUY18FYzh">
               <ce:text>ADME:</ce:text>
               <ce:keyword id="pc_Qsyx435bG5">
                  <ce:text>Absorption, Distribution, Metabolism and Excretion</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_GEAYSV0bZU">
               <ce:text>AMES:</ce:text>
               <ce:keyword id="pc_IXhodlcEjt">
                  <ce:text>Salmonella typhimurium reverse mutation assay</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_ts4ittEbcd">
               <ce:text>GLY:</ce:text>
               <ce:keyword id="pc_eLqZf8yNxL">
                  <ce:text>Glycine</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_0RLkLr4MP4">
               <ce:text>GLU:</ce:text>
               <ce:keyword id="pc_mHV7ELRDNk">
                  <ce:text>Glutamic acid</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_jmB9hhWA4t">
               <ce:text>HIS:</ce:text>
               <ce:keyword id="pc_0O6L8pLdqk">
                  <ce:text>Histidine</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_GO9KASzU3o">
               <ce:text>ASP:</ce:text>
               <ce:keyword id="pc_VK9t8Fm5fa">
                  <ce:text>Aspartic acid</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_QWXXLEU3lc">
               <ce:text>PHE:</ce:text>
               <ce:keyword id="pc_vobhN4oVRe">
                  <ce:text>Phenylalanine</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_PS35kYrTlI">
               <ce:text>VAL:</ce:text>
               <ce:keyword id="pc_rCfn4M7wiK">
                  <ce:text>Valine</ce:text>
               </ce:keyword>
            </ce:keyword>
            <ce:keyword id="pc_tthKYWLx7C">
               <ce:text>ASN:</ce:text>
               <ce:keyword id="pc_kS7xAPBhBZ">
                  <ce:text>Asparagine</ce:text>
               </ce:keyword>
            </ce:keyword>
         </ce:keywords>
      </ja:head>
   </ja:article>
</doc:document>
